CID 146267141

Vulolisib

Structural Information

Molecular Formula
C18H19F2N5O3S
SMILES
C[C@@H](C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4[C@@H](CSC4=O)C(F)F
InChI
InChI=1S/C18H19F2N5O3S/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11)24)25-12(15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21,26)/t9-,12-/m0/s1
InChIKey
KEEKMOIRJUWKNK-CABZTGNLSA-N
Compound name
(2S)-2-[[2-[(4R)-4-(difluoromethyl)-2-oxo-1,3-thiazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

2045
Patents

423.11768 Da
Monoisotopic Mass

2.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 424.12496 192.6
[M+Na]+ 446.10690 198.2
[M-H]- 422.11040 197.0
[M+NH4]+ 441.15150 202.1
[M+K]+ 462.08084 199.1
[M+H-H2O]+ 406.11494 183.0
[M+HCOO]- 468.11588 200.4
[M+CH3COO]- 482.13153 199.9
[M+Na-2H]- 444.09235 187.9
[M]+ 423.11713 189.2
[M]- 423.11823 189.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe